Medco Press Releases
|Print | E-mail Page | RSS | Alerts | IR Contacts | Financial Tear Sheet|
|Medco to Present at the Deutsche Bank 35th Annual Health Care Conference|
FRANKLIN LAKES, N.J., April 29, 2010 /PRNewswire via COMTEX/ --Timothy C. Wentworth, group president for employer accounts at Medco Health Solutions, Inc. (NYSE: MHS), is scheduled to address the Deutsche Bank 35th Annual Health Care Conference in Boston on Tuesday, May 4, 2010.
The presentation at the InterContinental Boston will begin at 10 a.m. EDT. Medco's Chief Financial Officer, Richard J. Rubino, is also scheduled to attend.
In addition, on Monday, May 3 at 2:50 p.m., Medco Chief Medical Officer and President of the Medco Research Institute, Dr. Robert Epstein, will discuss pharmacogenomics and personalized medicine on the "Next Generation Sequencing" panel discussion with Dr. Yardena Samuels, Head of Molecular Cancer Genetics at the National Institutes of Health.
Wentworth's presentation may be heard live via a simulcast link and the accompanying slides will be available at www.medco.com/investor. Real Player or Windows Media Player is required to listen to the webcast. Free downloads of both players are available at the webcast site. The webcast will be available for replay for one month following the presentation.
Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy(R) and its clinical research and innovations are part of Medco making medicine smarter(TM) for approximately 65 million members.
With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2009 revenues of nearly $60 billion, Medco ranks 35th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.
For more information, go to http://www.medcohealth.com.
This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.
SOURCE Medco Health Solutions, Inc.